ERBB3 and neoplasm: Because confirmed responses to HER3-DXd have been seen across a wide range of baseline tumor HER3 membrane H-scores, clinical activity of HER3-DXd has so far not shown direct correlation with baseline tumoral HER3 expression levels15,16,29.